The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or ...

During a Community Case Forum event in partnership with the Medical Oncology Association of Southern California, Edward S.

The FDA's nod is based on late-stage data, which show AZN's Datroway cuts the risk of disease progression/death by 37% vs ...

British drug maker AstraZeneca Plc (AZN.L, AZN) and Daiichi Sankyo (DSKYF.PK) announced Monday that their Datroway (datopotamab ...

Amgen’s LUMAKRAS and Vectibix combination has received approval from the US FDA for treating KRAS G12C-mutated mCRC.

“I went back to my GP three times before I was finally sent to hospital for an X-ray. It turned out that my lung had ...

Ameena Westwood, 53, started getting 'bad cough and shortness of breath' before being told her breast cancer had 'spread to ...

Cancer treatment is undergoing a revolution, and immunotherapy is leading the charge. Unlike traditional methods like ...

A report from Macmillan estimated a record 3.5m in the UK are living with cancer in 2025, including 98,000 in Northern ...

Amgen receives US FDA approval for Lumakras in combo with Vectibix for chemorefractory KRAS G12C-mutated metastatic colorectal cancer: Thousand Oaks, California Monday, January 20 ...

AstraZeneca announced on Monday that it has secured approval from the US Food and Drug Administration, alongside Daiichi ...

Cancer is now the second leading cause of death worldwide, and rates are climbing-especially in younger adults. Breast, ...